Los Angeles, CA, United States of America

Chi-Hong B Chen

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chi-Hong B Chen. Retrieved from https://idiyas.com/inventor/chi-hong-b-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chi-Hong B Chen: Innovator in Nucleic Acid Research

Introduction

Chi-Hong B Chen is an esteemed inventor based in Los Angeles, CA, known for his contributions to the field of biotechnology. With a focus on therapeutic applications, he has made significant strides through his innovative work at the University of California.

Latest Patents

Chi-Hong B Chen holds one patent titled "Aptamers to Human Epidermal Growth Factor Receptor-3." This patent involves compositions of nucleic acid aptamers that specifically bind to the human epidermal growth factor receptor-3, along with methods for their application. Such inventions possess the potential to advance therapeutic strategies targeting various diseases.

Career Highlights

Throughout his career, Chi-Hong B Chen has demonstrated a strong commitment to research and development in the field of molecular biology. His work not only contributes to academic knowledge but also has practical implications in the medical field.

Collaborations

Collaborating with Ralf Landgraf, Chi-Hong has enhanced his research's scope and impact. Together, they are working on advancing the understanding and applications of aptamer technology.

Conclusion

Chi-Hong B Chen's innovative efforts reflect a dedication to improving healthcare through biotechnology. His patent on aptamers signifies a vital step forward in harnessing the potential of molecular tools to address critical medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…